RxSight, Inc. — Director's Dealing 2025

Apr 16, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RxSight, Inc. (RXST)
CIK: 0001111485
Period of Report: 2025-04-14

Reporting Person: Thunen Shelley B (N/A)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-04-14	Common Stock	M	7792	$4.3386	Acquired	38354	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-04-14	Stock Option (right to buy)	$4.3386	M	6405	Disposed	2026-10-26	Common Stock (6405)	Direct
2025-04-14	Stock Option (right to buy)	$4.3386	M	1387	Disposed	2027-03-13	Common Stock (1387)	Direct

Footnotes

F1: Includes 119 shares of Common Stock acquired October 31, 2024 under the Issuer's 2021 Employee Stock Purchase Plan.

F2: Shares issued pursuant to the Issuer's 2015 Equity Incentive Plan, as amended.